Version 2.77


Meropenem is an ultra-broad spectrum antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta-lactam and belongs to the subgroup carbapenem. Meropenem was developed by Sumitomo Pharmaceuticals. It is marketed outside Japan by AstraZeneca under the brand names Merrem® and Meronem®. Unlike imipenem, it is not affected by the renal dehydrogenase and can therefore be given without cilastatin. It penetrates into the cerebrospinal fluid. Meropenem is less likely to cause seizures compared to imipenem. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See for details. Source: Wikipedia, Meropenem (Wikipedia)

Basic Part Properties

Part Display Name
Part Type
Component (Describes the core component or analyte measured)
Created On
Construct for LOINC Short Name

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup$lookup?system=
ConceptMap translate$translate?system=

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 美罗培南
Synonyms: 美洛培南
fr-CA French (Canada) Méropénem
et-EE Estonian (Estonia) Meropeneem
es-ES Spanish (Spain) Meropenem
it-IT Italian (Italy) Meropenem
tr-TR Turkish (Turkey) Meropenem
ru-RU Russian (Russian Federation) Меропенем
nl-NL Dutch (Netherlands) meropenem
fr-BE French (Belgium) Méropénem